These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18581679)

  • 1. [Peyronie's disease: treatment with interferon and laser].
    Candebat Montero LH; Miranda Reyes PL; Díaz García F; González Ferro I; Barbosa Ramos F; Codorniu Furet J
    Arch Esp Urol; 2008 Apr; 61(3):413-23. PubMed ID: 18581679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
    Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
    J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging.
    Polat O; Gül O; Ozbey I; Ozdikici M; Bayraktar Y
    Int Urol Nephrol; 1997; 29(4):465-71. PubMed ID: 9406006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
    Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
    J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
    Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
    J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peyronie's disease: review and recent advances.
    Langston JP; Carson CC
    Maturitas; 2014 Aug; 78(4):341-3. PubMed ID: 24984940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Management of Peyronie's Disease.
    Trost LW; Gur S; Hellstrom WJ
    Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
    Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
    Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional interferon-alpha-2B injections for the treatment of Peyronie's disease.
    Dang G; Matern R; Bivalacqua TJ; Sikka S; Hellstrom WJ
    South Med J; 2004 Jan; 97(1):42-6. PubMed ID: 14746421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
    Lacy GL; Adams DM; Hellstrom WJ
    Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
    Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
    J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Peyronie's disease with local interferon-alpha 2b.
    Brake M; Loertzer H; Horsch R; Keller H
    BJU Int; 2001 May; 87(7):654-7. PubMed ID: 11350406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional interferon in the treatment of Peyronie's disease: a pilot study.
    Judge IS; Wisniewski ZS
    Br J Urol; 1997 Jan; 79(1):40-2. PubMed ID: 9043494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
    Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
    J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Peyronie's disease with local interferon-alpha 2b.
    Wegner HE; Andresen R; Knipsel HH; Miller K
    Eur Urol; 1995; 28(3):236-40. PubMed ID: 8536778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
    Ralph DJ; Abdel Raheem A; Liu G
    J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peyronie's disease. Evaluation of 3 therapeutic modalities: propoleum, laser and simultaneous propoleum-laser].
    Lemourt Oliva M; Fragas Valdés R; Bordonado Ramírez R; Santana JL; González Oramas E; Merino A
    Arch Esp Urol; 2005 Nov; 58(9):931-5. PubMed ID: 16430041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
    Rehman J; Benet A; Melman A
    Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penile prosthesis implantation in the treatment of Peyronie's disease.
    Carson CC
    Int J Impot Res; 1998 Jun; 10(2):125-8. PubMed ID: 9647951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.